Clinical Trials Browser

NETWORK × Lymphoma, Mantle-Cell × Gemcitabine × Clear all

NCT00377052 2023-08-04

Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Mantle-Cell